Lane, JCE, Weaver, J, Kostka, K, Duarte-Salles, T, Abrahao, MTF, Alghoul, H, Alser, O, Alshammari, TM, Biedermann, P, Banda, JM, Burn, E, Casajust, P, Conover, MM, Culhane, AC, Davydov, A, DuVall, SL, Dymshyts, D, Fernandez-Bertolin, S, Fister, K, Hardin, J, Hester, L, Hripcsak, G, Kaas-Hansen, BS, Kent, S, Khosla, S, Kolovos, S, Lambert, CG
, Lei, J, Lynch, KE, Makadia, R, Margulis, AV, Matheny, ME, Mehta, P, Morales, DR, Morgan-Stewart, H
, Mosseveld, BMT, Newby, D, Nyberg, F, Ostropolets, A, Park, RW, Prats-Uribe, A, Rao, GA, Reich, C, Reps, J
, Rijnbeek, P, Sathappan, SMK
, Schuemie, M, Seager, S, Sena, AG, Shoaibi, A, Spotnitz, M, Suchard, MA, Torre, CO, Vizcaya, D, Wen, HN
, de Wilde, M, Xie, JQ, You, SC, Zhang, L, Zhuk, O, Ryan, P & Prieto-Alhambra, D 2020, '
Risk of hydroxychloroquine alone and in combination with azithromycin in the treatment of rheumatoid arthritis: a multinational, retrospective study',
The Lancet Rheumatology, vol. 2, no. 11, pp. E698-E711.
https://doi.org/10.1016/s2665-9913(20)30276-9